Money · Lobbying reports · 119th Congress
H.R. 6423
16 saved lobbying reports name H.R. 6423.
16 reports
Confirmed from the official recordSenate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Lobbying Disclosure Act reports, LDA.gov. This copy was read October 8, 2026 at 1:49 AM Eastern.
Reports that name this bill
The amount is what the report gives for the whole quarter: everything the registrant did for that client, all issues together. A linked name opens that organization’s page on this site.
| Registrant | Client | Amount for the whole quarter | Quarter | Report |
|---|---|---|---|---|
| CROHN'S & COLITIS FOUNDATION | CROHN'S & COLITIS FOUNDATION | $40,000.00reported as expenses | April to June 2026 | Open the report |
| VERTEX PHARMACEUTICALS INCORPORATED | VERTEX PHARMACEUTICALS INCORPORATED | $1,200,000.00reported as expenses | April to June 2026 | Open the report |
| ASSOCIATION FOR CLINICAL ONCOLOGY | ASSOCIATION FOR CLINICAL ONCOLOGY | $480,000.00reported as expenses | April to June 2026 | Open the report |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | $890,000.00reported as expenses | April to June 2026 | Open the report |
| UCB, INC. | UCB, INC. | $710,000.00reported as expenses | April to June 2026 | Open the report |
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. | AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC | $1,240,000.00reported as expenses | April to June 2026 | Open the report |
| ARTEMIS POLICY GROUP LLC | THE HEMOPHILIA ALLIANCE | $30,000.00reported as income | April to June 2026 | Open the report |
| ARTEMIS POLICY GROUP LLC | NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) | $50,000.00reported as income | April to June 2026 | Open the report |
| EPILEPSY FOUNDATION | EPILEPSY FOUNDATION | $150,000.00reported as expenses | April to June 2026 | Open the report |
| THE ALS ASSOCIATION | THE ALS ASSOCIATION | $30,000.00reported as expenses | April to June 2026 | Open the report |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $7,360,000.00reported as expenses | April to June 2026 | Open the report |
| CYSTIC FIBROSIS FOUNDATION | CYSTIC FIBROSIS FOUNDATION | $270,000.00reported as expenses | April to June 2026 | Open the report |
| VENABLE LLP | PATIENT ACCESS NETWORK FOUNDATION | $40,000.00reported as income | April to June 2026 | Open the report |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | $2,360,000.00reported as expenses | April to June 2026 | Open the report |
| SANOFI US SERVICES INC. | SANOFI US SERVICES INC | $920,000.00reported as expenses | April to June 2026 | Open the report |
| THE KPM GROUP DC LLC | SOLENO THERAPEUTICS, INC. | $10,000.00reported as income | April to June 2026 | Open the report |